Skip to main content Skip to main navigation menu Skip to site footer

Quality of life in onychomycosis patients at H. Adam Malik General Hospital, Medan - Indonesia, 2016

  • Gustina Putri ,
  • Isma Aprita Lubis ,
  • Imam Budi Putra ,

Abstract

Background: Onychomycosis describes fungal infection of the nail caused by dermatophytes, non-dermatophytes molds, or yeast. It affects up to 14% of the population worldwide. Although onychomycosis is not a life-threatening condition, the disease does not only appear to be a cosmetic problem, it has been suggested that patient can experience deleterious psychologic effects. Onychomycosis has the psychological, psychosocial, and emotional impact that reduce patient’s quality of life.

Objective: To determine the quality of life in onychomycosis patients.

Subject and methods: This research was a descriptive study with a cross-sectional design involving 43 onychomycosis patients. The diagnosis of onychomycosis was confirmed by physical examination and fungal culture. Each subject answered NailQoL questionnaires and the results were assessed. Value with a higher score shows the lower quality of life.

Result:  Quality of life in the most onychomycosis patients was the lower quality of life with the value of NailQoL in the number of ≥37 (41,9%). Based on the gender, the female had the lower quality of life (41,9%). Based on the age, patients in 30-39 years old group had the lower quality of life (62,5%). Based on the education level, patients who went to university had lower quality of life (50,0%). Based on patient’s occupation, the student has the lower quality of life (100%). Based on the duration of illness, patients with more than 10 years duration of illness had a lower quality of life (60,0%). Based on the number of nail involvement, patients with 11-15 nails and 16-20 nails involvement had the lower quality of life (100%).  

Conclusion: Quality of life in the most of onychomycosis patients was the lower quality of life. The lower quality of life was more common in female patients, patients in 30-39 years old group, university education level, students, >10 years duration of illness,                       11-15 and 16-20 number of nails involvement. 

 

References

  1. Schieke SM, Garg A. Superficial Fungal Infection. In: Goldsmith LA, Katz SI, Gilchrist BA, Paller AS, Leffel DJ, Wolff K, editors. Fitzpatrick’s Dermatology in General Medicine. 8th ed. New York: McGraw Hill Companies; 2012.p.1425-7.
  2. Nasution MA. Mikologi dan mikologi kedokteran beberapa pandangan dermatologis [Pidato Pengukuhan Jabatan Guru Besar Tetap]. Medan: Universitas Sumatera Utara; 2005.
  3. Kaur R, Kashyap B, Bhalla P. Onychomycosis-epidemiology, diagnosis and management. Indian Journal of Medical Microbiology [Internet]. 2008. [cited 2015 January 20] ;26(2): 108-16.
  4. Available from: http://www.ijmm.org/article.asp?issn=0255-0857
  5. Singal A, Khanna D. Onychomycosis: diagnosis and management. IJDVL [Internet]. 2011.[cited 2015 January 13];77(6):659-72. Available from: http://www.mdlinx.com/internal-medicine/news-article-exit-page.cfm/380366
  6. Rizal F. Sensitivitas dan spesifisitas pewarnaan PAS (Periodic Acid Schiff) dan kultur untuk mendiagnosis onikomikosis [Thesis] Medan: Universitas Sumatera Utara; 2010.
  7. Ahmed R, Kharal SA, Durrani MA, Sabit M, Chang AH, Fakhrudin. Frequency of candida in onychomycosis. J Pak Med Assoc [Internet]. 2013. [cited 2015 September 20];63(3):350-53. Available from: http://jpma.org.pk/PdfDownload/4060.pdf
  8. Chacon A, Franca K, Fernandez A, Nouri K. Psychosocial Impact of Onychomycosis: a review. International Journal of Dermatology. 2013;52:1300-7. Doi: 10.1111/ijd.12122
  9. Szepietowski JC, Reich A, Pacan P, Garlowska B. Evaluation of Quality of Life in Patient with Toenail Onychomycosis by Polish Version of an International Onychomycosis-spesific Questionnaire. European Academy of Dermatology and Venereology.2007;21:491-6. Doi: 10.1111/j.1468-3083.2006.02004.x
  10. Gelotar P, Vachhani S, Patel B, Makwana N. The prevalence of fungi in fingernail onychomycosis. Journal of Clinical and Diagnostic Research[Internet]. 2013. [cited 2015 September 21] ;7(2):250-52. Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592285
  11. Szepietowski JC, Reich A. Stigmatisation in Onychomycosis Patient: a Population-based Study. Journal compilation.2008;52:344-8. Doi: 10.1111/j.1439-0507.2008.01618.x
  12. Health-Related Quality of Life and Well-Being. Healthy People 2020 [Internet]. 2010; [cited 2014 November 20]. Available from: http://healthypeople.gov/2020/about/qolwbabout.aspx
  13. Health-Related Quality of Life (HRQL). CDC [Internet]. [cited 2014 December 2] Available from: http://cdc.gov/hrqol/concept.htm
  14. Wilson IB, Cleary PD. Linking Clinical Variables With Health-Related Quality of Life. Journal of the American Medical Association. 1995; 273(1): 59-65. Doi:10.1001/jama.1995.03520250075037
  15. Warshaw EM, Foster JK, Cham PM. NailQol: a Quality of Life Instrument for Onychomycosis. The International Society of Dermatology. 2007;46:1279-86. Doi: 10.1111/j.1365-4632.2007.03362.x.
  16. Turner RR, Testa MA. Measuring the Impact of Onyhomychosis on Patient Quality of Life. Quality of Life Research. 2000; 9: 39-53. Doi 10.1023/A:1008986826756
  17. Cham PMH, Chen SC, Grill JP. Validity of Self-Reported Nail Counts in Patients with Onychomycosis: A Retrospective Pilot Analysis. American Academy of Dermatology. 2008;58(1):136-41. Doi: http://dx.doi.org/10.1016/j.jaad.2007.09.022
  18. Elewski BE. The Effect of Toenail Onychomycosis on Patient Quality of Life. International Journal of Dermatology. 1997;36:754-6. Doi: 10.1046/j.1365-4362.1997.00163.x
  19. Nijsten T, Sampogna F, Abeni D. Categorization of skindex-29 scores using mixture analysis. Dermatology. 2009; 218: 151-4. doi:10.1159/000182253
  20. Both H. Critical Review of Generic and Dermatology-spesific Health Related Quality of Life Instrument. Journal of Investigative Dermatology . 2007; 127:2726-39. Doi:10.1038/sj.jid.5701142
  21. Drake LA, Patrick DL. The Impact of Onychomycosis on Quality of Life: Development of an International Onychomycosis-specific Questionnaire to Measure Patient Quality of Life. J Am Acad Dermatol. 1999;41(2):189-96. Doi: 10.1111/j.1365-2230.1997.tb02626.x
  22. Drake LA, Scher RK. Effect of Onychomycosis on Quality of Life. American Academy of Dermatology. 1998;38(5):702-4. Doi: http://dx.doi.org/10.1016/S0190-9622(98)70199-9
  23. Scher RK. Onychomycosis: A Significant Medical Disorders. American Academy of Dermatology.1996;(35)3:S2-S5.doi:http://dx.doi.org/10.1016/S0190 9622(96)90061-4
  24. Lubeck DP. Measuring Health-Related Quality of Life in Onychomycosis. American Academy of Dermatology.1998;38(5):64-8. doi: http://dx.doi.org/10.1016/S0190-9622(98)70487-6
  25. Drake L. Quality of life issues for patients with fungal nail infections. AIDS Pat Care 1995;9:S15-7.
  26. Milobratovic D, Jankovic S, Vukicevic J, Marinkovic J, Jankovic Janko, Railic Zoran. Quality of Life in Patients with Toenail Onychomyccosis. Blackwell Veriag GmbH Mycoses. 2013;56: 543-51. Doi:10.1111/myc.12072

How to Cite

Putri, G., Lubis, I. A., & Putra, I. B. (2018). Quality of life in onychomycosis patients at H. Adam Malik General Hospital, Medan - Indonesia, 2016. Bali Medical Journal, 7(3). https://doi.org/10.15562/bmj.v7i3.998

HTML
12

Total
5

Share

Search Panel